CHICAGO - Participants at the FDA's first public meeting on food biotechnology lined up into three opposing teams that, judging from the tone and content of their rhetoric, seemed to have little in common.

Biotech industry representatives and their teammates in the farming and food manufacturing sectors argued that biotechnology is safe, that they have the science to prove it, and that FDA's policies on regulating and labeling foods produced through biotech are exemplary.